These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8891915)

  • 21. Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine.
    Zaitsu K; Katagi M; Kamata HT; Kamata T; Shima N; Miki A; Tsuchihashi H; Mori Y
    Forensic Sci Int; 2009 Jul; 188(1-3):131-9. PubMed ID: 19406592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural elucidation of an uncommon phenylethylamine analogue in urine responsible for discordant amphetamine immunoassay results.
    Marson C; Schneider S; Meys F; Wennig R
    J Anal Toxicol; 2000; 24(1):17-21. PubMed ID: 10654564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
    Maresová V; Chadt J; Prikryl L
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excretion of MBDB and BDB in urine, saliva, and sweat following single oral administration.
    Kintz P
    J Anal Toxicol; 1997; 21(7):570-5. PubMed ID: 9399128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry.
    Ewald AH; Peters FT; Weise M; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):123-31. PubMed ID: 16027051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitation of N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in human plasma by high-performance liquid chromatography and fluorescence detection.
    Brunnenberg M; Lindenblatt H; Gouzoulis-Mayfrank E; Kovar KA
    J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):79-85. PubMed ID: 9869367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma.
    Kolbrich EA; Lowe RH; Huestis MA
    Clin Chem; 2008 Feb; 54(2):379-87. PubMed ID: 18089653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA) enantiomers by GC-MS.
    Hensley D; Cody JT
    J Anal Toxicol; 1999 Oct; 23(6):518-23. PubMed ID: 10517560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector.
    Lim HK; Foltz RL
    Chem Res Toxicol; 1988; 1(6):370-8. PubMed ID: 2908769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry.
    Kikura-Hanajiri R; Kawamura M; Miyajima A; Sunouchi M; Goda Y
    Forensic Sci Int; 2010 May; 198(1-3):62-9. PubMed ID: 20299167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine.
    Shima N; Kamata H; Katagi M; Tsuchihashi H; Sakuma T; Nemoto N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):123-9. PubMed ID: 17643356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enantioselective quantitation of the ecstasy compound (R)- and (S)-N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in human plasma and urine.
    Buechler J; Schwab M; Mikus G; Fischer B; Hermle L; Marx C; Grön G; Spitzer M; Kovar KA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Aug; 793(2):207-22. PubMed ID: 12906896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy').
    Maurer HH; Bickeboeller-Friedrich J; Kraemer T; Peters FT
    Toxicol Lett; 2000 Mar; 112-113():133-42. PubMed ID: 10720722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of Abusign drugs-of-abuse slide tests with particluar emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MS.
    Ros JJ; Pelders MG; Egberts AC
    J Anal Toxicol; 1998; 22(1):40-4. PubMed ID: 9491967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats.
    Yousif MY; Fitzgerald RL; Narasimhachari N; Rosecrans JA; Blanke RV; Glennon RA
    Drug Alcohol Depend; 1990 Oct; 26(2):127-35. PubMed ID: 1978707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry.
    Staack RF; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 773(1):35-46. PubMed ID: 12015268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA.
    Valtier S; Phelix CF; Cody JT
    J Anal Toxicol; 2007 Apr; 31(3):138-43. PubMed ID: 17579960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicological detection of selegiline and its metabolites in urine using fluorescence polarization immunoassay (FPIA) and gas chromatography-mass spectrometry (GC-MS) and differentiation by enantioselective GC-MS of the intake of selegiline from abuse of methamphetamine or amphetamine.
    Maurer HH; Kraemer T
    Arch Toxicol; 1992; 66(9):675-8. PubMed ID: 1482291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicological detection of pholcodine and its metabolites in urine and hair using radio immunoassay, fluorescence polarisation immunoassay, enzyme immunoassay, and gas chromatography-mass spectrometry.
    Maurer HH; Fritz CF
    Int J Legal Med; 1990 Dec; 104(1):43-6. PubMed ID: 11453092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS.
    Zhao H; Brenneisen R; Scholer A; McNally AJ; ElSohly MA; Murphy TP; Salamone SJ
    J Anal Toxicol; 2001; 25(4):258-69. PubMed ID: 11386639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.